Skip to content

Clinical trials

Completed Atherosclerosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20093
20112
20123
20131
20141
20182
20191
20202
20223
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Boston Scientific Corporation3
Amgen2
480 Biomedical1
Abbott Medical Devices1
AstraZeneca1
Biotronik AG1
Bristol-Myers Squibb1
CSL Behring1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis23
Cardiovascular Diseases7
Coronary Artery Disease4
Peripheral Arterial Disease4
Coronary Disease3
Heart Diseases3
Acute Coronary Syndrome2
Dyslipidemias2
Heart Failure2
Hyperlipidemias2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.